On October 20, Karin Agerman, Chief Research & Development Officer at CombiGene presented on ATMP Sweden’s webinar Manufacturing of Gene Therapy Products in Sweden. Karin gave her views on the production of gene therapies in Sweden under the heading A small company’s perspective on manufacture of in vivo gene therapy in Sweden for clinical trial.
If you didn’t have the opportunity to follow the presentation live, you can now view it here https://www.youtube.com/watch?v=SYbm4a883JY&t (about 22 minuts in the presentation)
